A vaccine that Novavax developed to deter the virus that causes most lung infections generated the desired immune response in children,…
Articles by Alice Melão, MSc
Results of a Phase 3 trial of the investigational drug revefenacin (TD-4208) for the treatment of moderate to very severe…
Severe cases of chronic obstructive pulmonary disease (COPD) can lead to structural changes in the lungs. These changes not only…
Patients with chronic obstructive pulmonary disease (COPD) who also have non-tuberculous mycobacterial pulmonary disease (NTM-PD) are more likely to be…